Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

Kersten, JR; Montgomery, MW; Ghassemi, T; Gross, ER; Toller, WG; Pagel, PS; Warltier, DC.
Diabetes and hyperglycemia impair activation of mitochondrial K(ATP) channels.
AMER J PHYSIOL-HEART CIRC PHY 2001 280: H1744-H1750. Doi: 10.1152/ajpheart.2001.280.4.H1744 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Toller Wolfgang
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Hyperglycemia is an important predictor of cardiovascular mortality in patients with diabetes. We investigated the hypothesis that diabetes or acute hyperglycemia attenuates the reduction of myocardial infarct size produced by activation of mitochondrial ATP-regulated potassium (K(ATP)) channels. Acutely instrumented barbiturate-anesthetized dogs were subjected to a 60-min period of coronary artery occlusion and 3 h of reperfusion. Myocardial infarct size (triphenyltetrazolium chloride staining) was 25 +/- 1, 28 +/- 3, and 25 +/- 1% of the area at risk (AAR) for infarction in control, diabetic (3 wk after streptozotocin-alloxan), and hyperglycemic (15% intravenous dextrose) dogs, respectively. Diazoxide (2.5 mg/kg iv) significantly decreased infarct size (10 +/- 1% of AAR, P < 0.05) but did not produce protection in the presence of diabetes (28 +/- 5%) or moderate hyperglycemia (blood glucose 310 +/- 10 mg/dl; 23 +/- 2%). The dose of diazoxide and the degree of hyperglycemia were interactive. Profound (blood glucose 574 +/- 23 mg/dl) but not moderate hyperglycemia blocked the effects of high-dose (5.0 mg/kg) diazoxide [26 +/- 3, 15 +/- 3 (P < 0.05), and 11 +/- 2% (P < 0.05), respectively]. There were no differences in systemic hemodynamics, AAR, or coronary collateral blood flow (by radioactive microspheres) between groups. The results indicate that diabetes or hyperglycemia impairs activation of mitochondrial K(ATP) channels.
Find related publications in this database (using NLM MeSH Indexing)
Analysis of Variance -
Animals -
Blood Glucose - metabolism
Blood Pressure - metabolism
Carbon Dioxide - blood
Coronary Circulation - drug effects
Coronary Vessels - drug effects
Diabetes Mellitus, Experimental - physiopathology
Diazoxide - pharmacology
Dogs - pharmacology
Endocardium - drug effects
Heart Rate - drug effects
Hemodynamic Processes - drug effects
Humans - drug effects
Hyperglycemia - physiopathology
Membrane Proteins - physiology
Mitochondria - physiology
Myocardial Infarction - pathology
Oxygen - blood
Potassium Channels - blood
Research Support, Non-U.S. Gov't - blood
Research Support, U.S. Gov't, P.H.S. - blood
Vasodilator Agents - pharmacology
Ventricular Function, Left - pharmacology

Find related publications in this database (Keywords)
myocardial infarction
© Med Uni GrazImprint